SCHAUMBURG, Ill., May 14 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it will contribute US$20,000 to the American Red Cross to assist the victims of Monday’s earthquake in central China.
“As a part of the global community, we were saddened by the devastation experienced by the people of the Sichuan province,” said Jeffrey M. Yordon, chief executive officer, founder, and chairman of the board of Sagent. “We hope our contribution to the recovery efforts there will help in some small way ease the burden for the Sichuan residents.”
The earthquake’s epicenter was 55 miles from Chengdu, Sichuan Province’s capital with a population of 12 million people. In conjunction with its local joint venture partners, Chengdu Great Southwest Pharmaceutical Co., Ltd., Sagent is presently constructing an FDA-compliant, sterile, injectable, finished product manufacturing facility in Chengdu.
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, founded in 2006, is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.
To Discover Injectables Excellence(TM) and learn more about Sagent, please visit http://www.SagentPharma.com.
CONTACT: Investors, Ronald E. Pauli of Sagent Pharmaceuticals, Inc.,
+1-847-908-1604; or Rebekah Brooks of WeissComm Partners, +1-312-284-4707,
for Sagent Pharmaceuticals, Inc.
Web site: http://www.SagentPharma.com/
